ESOTA continues to develop and grow, now including over 200 participating hospitals in 6 countries. Member stroke research networks include Netherlands (CONTRAST), Stroke Trials Network Ireland, the UK Clinical Research Network, Swiss Stroke Trials Network, Spanish Stroke Society Network, and Scotland Stroke Research Network. Up to 6 more countries are expected to join by 2021.

At ESOC, ESOTA held a successful symposium to discuss trials and related studies in member networks. Prof Gotz Thomalla described practical issues about running a multinational EU-funded trial in Europe.  ESOTA also hosted a well-attended teaching symposium on trial design and operation in Europe. Prof Peter Kelly spoke at the Women Initiative for Stroke in Europe (WISE) workshop on supporting women in clinical research in ESO.

A review paper ‘Building a European network of networks for stroke clinical research – the ESO Trials Alliance’ was published in the European Stroke Journal. This and related materials are available on the ESOTA website (https://www.eso-trialsalliance.org/).

The main goal of ESOTA is to make it easier for ESO investigators to conduct multinational stroke trials in Europe. ESOTA investigators seeking collaborators for their trials should contact Luzia Balmer (luzia.balmer@eso-stroke.org) to be connected with network investigators in other countries. 

Stroke research networks who have not yet joined ESOTA but wish to do so are encouraged to check the membership information on the website and contact Luzia for further information.

About ESO Committees

ESO committees aim to further the mission of ESO and are comprised of dedicated ESO members. All members in good standing are encouraged to join a committee which aligns with their interests. Members can nominate themselves or someone else for committee membership. There are no additional fees associated with committee membership.

Learn more about all of ESO`s committees and their work. To make a nomination, scroll to the bottom of the page and submit a completed eform.